The India’s leading pharmaceutical company Mankind Pharma IPO will be hit the market 25 April 2023 and closes on 27 April 2023. The Company has filed the RHP of this IPO. According to RHP, the company wants to raise approx ₹₹4,326.36 crore through IPO. The company will issue only Offer for sale through this IPO and will issue shares through an offer for sale of 40,058,844 Shares.
The company has reserved 50% for QIB, 15% for NII and 35% for Retail Investor in this IPO.
Mankind Pharma limited India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022. The company engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. You can check Mankind Pharma IPO GMP here.
| Read also: Upcoming IPO List 2022 |
The company product portfolio comprises a broad range of formulations across various acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients and respiratory in our consumer healthcare business. The company have established several differentiated brands in the condoms, pregnancy detection, oral contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories.
Some of the highest selling pharmaceutical brands of the company: Manforce, Candiforce, Dydroboon, Nurokind-LC, Telmikind-H Moxikind-CV, Gudcef, Codistar, Asthakind-DX, Telmikind. Amlokind-AT, Glimestar-M, Nurokind-Gold, Cefakind, Gudcef-CV, Unwanted-Kit, Prega News, Nurokind Plus-RF, Monticope, Unwanted-72, etc. you can check Mankind Pharma IPO subscription status here.
The company have a pan-India marketing presence, with a field force of 11,196 medical representatives and 3,195 field managers, as of March 31, 2022. We have also established a significant distribution network in India and, during the Financial Year 2022. The company sold our products to over 11,000 stockists and engaged with 75 clearing and forwarding (“C&F”) agents. As a result, we have an established presence in the IPM with pan-India coverage. During the Financial Year 2022, our Domestic Sales in the North India, South India, East India and West India
The company operate 23 manufacturing facilities across India and had 2,181 manufacturing personnel as of March 31, 2022. The company formulations manufacturing facilities have a total installed capacity of 40.77 billion units across a wide range of dosage forms including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products, as of March 31, 2022.
The company have developed a portfolio of differentiated products across several therapeutic areas. As of March 31, 2022, the Company had a team of over 600 scientists and a dedicated in-house R&D center with three units located in IMT Manesar, Gurugram, Haryana. you can check Mankind Pharma IPO allotment status here.
Object Of the Issue :
- Offer Proceeds will be received by the Selling Shareholders, in proportion to the Offered Shares sold by the respective Selling Shareholders as part of the Offer.
Company Strengths :
- Strong and diverse existing portfolio base.
- Established track record, favourable national policy support and visibility for future growth.
- Reliable cash flow supported by long-term O&M contracts with high credit quality counterparties.
- Supported and promoted by our parent company, IWL.
- Established supply chain in place.
- Strong and experienced management team.
Mankind Pharma IPO Review :
| Details | Valuation |
| PAT 2022 : Issue Price : EPS 2022 : PE Ratio : RoNW : NAV Value : Total Assets : Market Cap : Pre Holding : Post Holding : | ₹1452.96 Cr (March 2022) ₹1080/ EQ (Cut Off) 35.78 (March 2022) 38.58x (PE Approx) 23.29% (March 2022) ₹153.65 (March 2022) ₹9273.75 Cr (Dec 2022) ₹43263.60 Cr 79.00% 76.50% |
| Team Review : | ✔ Apply For Long Term |
Mankind Pharma IPO Date & Price Band & Details :
| IPO Open : | 25 April 2023 |
| IPO Close : | 27 April 2023 |
| IPO Size : | ₹4,326.36 Cr {40,058,844 Shares} |
| Face Value : | ₹1. Equity Share |
| Price Band : | ₹1026 – ₹1080 Per Share |
| Listing On : | BSE, NSE |
| Issue Size : | ₹4,326.36 Cr {40,058,844 Shares} |
| Fresh Issue : | N/A |
| Offer For Sale : | ₹4,326.36 Cr {40,058,844 Shares} |
Mankind Pharma IPO Market Lot :
Mankind Pharma IPO Minimum Market lot is 1 Lot with 13 shares with ₹14,040 Application amount. The retail investors can apply up to 14 lots with 182 Shares or ₹196,560 amounts.
| Application | Lot | Shares | Amount |
| Retail Minimum : | 1 | 13 | ₹14,040 |
| Retail Maximum : | 14 | 182 | ₹196,560 |
| S-HNI Minimum : | 15 | 195 | ₹210,600 |
| B- HNI Minimum : | 71 | 936 | ₹10,10,880 |
Mankind Pharma IPO Shares Offer :
A Total of 40,058,844 shares are to be bid for the public issue by Mankind Pharma IPO with – for Fresh issue and 40,058,844 for offer for sale Shares.
| Category | Shares Offers | Amount |
| Fresh issue : | – | ₹- |
| Offer For Sale : | 40,058,844 | ₹4,326.36 Cr |
| Total : | 40,058,844 | ₹4,326.36 Cr |
Mankind Pharma IPO Reservation :
Mankind Pharma IPO Total Reservation of 40,058,844 shares are to be bid for the public issue by Mankind Pharma IPO with 20,029,422 for QIB and 60,08,827 for NII 14,020,595 For RII & – Shares EMP.
| Category | Reservation | Shares | Amount |
| QIB : | 50% | 20,029,422 | ₹2163.18 Cr |
| NII : | 15% | 60,08,827 | ₹648.95 Cr |
| RII : | 35% | 14,020,595 | ₹1514.22 Cr |
| EMP : | – % | – | ₹- |
| Total : | 100% | 40,058,844 | ₹4326.36 Cr |
Mankind Pharma IPO EPS & RoNW :
The Mankind Pharma company’s EPS growth & RoNW is Increasing every year, which is shown to you in the table here.
| Year | EPS Growth in (Rs.) | Return On Net Worth % |
|---|---|---|
| 2022 | ₹35.78 | 23.39 % |
| 2021 | ₹31.59 | 26.80 % |
| 2020 | ₹25.72 | 29.56 % |
Mankind Pharma IPO Peer Comparison PE :
The Mankind Pharma, According to DRHP of the company some company is listed whose PE Multiple is shown in below images.
Mankind Pharma IPO Dates :
Mankind Pharma IPO Date is 25 April 2023 an closes on 27 April 2023. The allotment will be finalized on 03 April 2023 and the IPO may list on 08 May 2023.
| Open Date : | 25 April 2023 |
| Close Date : | 27 April 2023 |
| Allotment Date : | 03 May 2023 |
| Refund Date : | 04 May 2023 |
| Share Credit Date : | 05 May 2023 |
| Listing Date : | 08 May 2023 |
Mankind Pharma IPO Form :
There are two ways to apply in Mankind Pharma IPO. You can apply for Mankind Pharma IPO through ASBA available in your bank account. You have to go to your online bank login and select Mankind Pharma IPO in the Invest section and apply through your bank account. Another option is you can apply for Mankind Pharma IPO through IPO form download through NSE and BSE. See the Mankind Pharma IPO Form – Download the NSE Form and BSE Form IPO Form, fill it, and submit it to your bank or your broker.
Mankind Pharma Company Financial Report (In Cr) :
| Year | Revenue | Expense | PAT |
| 2022 | ₹79,77.58 | ₹60,17.43 | ₹1452.96 |
| 2021 | ₹63,85.38 | ₹47,05.44 | ₹1293.03 |
| 2020 | ₹59,75.65 | ₹45,49.45 | ₹1056.14 |
Company Promoters :
■ Ramesh Juneja
Quick Link :
■ DRHP Draft Prospectus
■ RHP Draft Prospectus
■ Anchor Investor
Mankind Pharma IPO Lead Managers :
■ Kotak Mahindra Capital Company Limited
■ Axis Capital Limited
■ J.P. Morgan India Private Limited
■ Jefferies India Private Limited
■ IIFL Securities Limited
Mankind Pharma IPO Registrar :
KFin Technologies Limited
Selenium, Tower B,
Plot No. 31 and 32 Financial District,
Nanakramguda, Serilingampally,
Hyderabad, Rangareddi 500 032,
Telangana, India
Tel: +91 40 6716 2222
E-mail: [email protected]
Investor Grievance E-mail: [email protected]
Website: www.kfintech.com
Note: Check Mankind Pharma IPO allotment status Visit IPOBAZAR Allotment Page And Search Your Registrar IPO Allotment Link. Click Here
Company Address :
Mankind Pharma Private Limited
Okhla Industrial Estate,
Phase-III, New Delhi 110 020,
Delhi, India
Tel: +91 11 4747 6600
E-mail: [email protected]
Website: www.mankindpharma.com
Mankind Pharma IPO FAQs :
What is Mankind Pharma IPO?
Mankind Pharma IPO is Mainboard IPO. They are going to raise ₹4,326.36 Crores via IPO. The issue is priced at ₹1026-₹1080 per equity share. The IPO is to be listed on NSE, BSE.
When Mankind Pharma IPO will open?
The IPO is to open on 25 Apr – 27 Apr for QIB, NII & RII.
What is Mankind Pharma IPO Size?
Mankind Pharma IPO size is ₹4,326.36 Crores.
What is the Fresh issue size of Mankind Pharma IPO?
The Fresh issue size of Mankind Pharma IPO ₹0 Cr.
What is the Offer For Sale size of Mankind Pharma IPO?
The Offer For Sale size of Mankind Pharma IPO ₹4,326.36 Cr.
What is Mankind Pharma IPO Price Band?
Mankind Pharma IPO Price Band is ₹1026-₹1080 Per share.
What is Mankind Pharma IPO Minimum and Maximum Lot Size?
The minimum 13 Shares with ₹14,040 amount while the maximum 182 shares with ₹196,560.
What is Mankind Pharma IPO Investors Portion?
The investors’ portion for QIB 50%, NII 15%, RII 35%.
What is Mankind Pharma IPO Allotment Date?
Mankind Pharma IPO allotment date is 03 May 2023.
What is Mankind Pharma IPO Listing Date?
Mankind Pharma IPO listing date is 08 May 2023. The IPO to list on NSE, BSE.
How to Apply the Mankind Pharma IPO through Zerodha?
Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Mankind Pharma IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Mankind Pharma IPO through Upstox?
Log in to Upstox Website or app. Go to Portfolio and Click on IPO. You will see the IPO Name “Mankind Pharma IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Mankind Pharma IPO through Groww?
Log in to Groww Website or app. Now you can see IPOs and Click on IPO. You will see the IPO Name “Mankind Pharma IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Mankind Pharma IPO through Paytm Money?
Log in to the Paytm Money Website or app. Now you can see Invest is IPOs Section and Click on IPO. You will see the IPO Name “Mankind Pharma IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
| Mankind Pharma IPO GMP: Click Here Mankind Pharma IPO Subscription: Click Here Mankind Pharma IPO Allotment: Click Here Mankind Pharma IPO Listing: Click Here |
All Mankind Pharma IPO-related links are available here. If you want to know the details then click on Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.